Non-publication of large randomized clinical trials: Cross sectional analysis

BMJ (Online)

Volumn 347, Issue , 2013, Pages

  Jones, Christopher W ^a   Handler, Lara ^b   Crowell, Karen E ^b   Keil, Lukas G ^c   Weaver, Mark A ^d   Platts Mills, Timothy F ^c  

^a Cooper Medical School of Rowan University ^*  (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CROSS-SECTIONAL STUDY; DATA BASE; INFORMATION PROCESSING; INFORMATION RETRIEVAL; INFORMATION SEEKING; OUTCOME ASSESSMENT; PEER REVIEW; PRIORITY JOURNAL; PUBLICATION; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGISTER;

ACCESS TO INFORMATION; CROSS-SECTIONAL STUDIES; PUBLISHING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES; TIME FACTORS;

EID: 84888189952     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f6104     Document Type: Article

References (53)

1. Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA 2000;283:2701-11.
2. Moreno J, Caplan AL, Wolpe PR. Updating protections for human subjects involved in research. Project on Informed Consent, Human Research Ethics Group. JAMA 1998;280:1951-8.
3. Food and Drug Administration Modernization Act of 1997. US Public Law 105-15. (1997, Nov 21); 21 USC 301.
4. De Angelis C, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. N Engl J Med 2004;351:1250-1.
5. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c869.
6. Food and Drug Administration Amendments Act of 2007. US Public Law 110-85. (2007, Sept 27); 21 USC 301.
7. ClinicalTrials.gov. FDAAA 801 requirements. National Institutes of Health.
8. Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 2004;363:1341-5.
9. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008;358:252-60.
10. Hart B, Lundh A, Bero L. Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses. BMJ 2012;344:d7202.
11. Rising K, Bacchetti P, Bero L. Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. PLoS Med 2008;5:e217; discussion e217.
12. Jefferson T, Jones MA, Doshi P, Del Mar CB, Heneghan CJ, Hama R, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev 2012;(1):CD008965.
13. Gibson LM, Brazzelli M, Thomas BM, Sandercock PA. A systematic review of clinical trials of pharmacological interventions for acute ischaemic stroke (1955-2008) that were completed, but not published in full. Trials 2010;11:43.
14. Munro AJ. Publishing the findings of clinical research. BMJ 1993;307:1340-1.
15. Pearn J. Publication: an ethical imperative. BMJ 1995;310:1313-5.
16. Zarin DA, Ide NC, Tse T, Harlan WR, West JC, Lindberg DA. Issues in the registration of clinical trials. JAMA 2007;297:2112-20.
17. Zarin DA, Tse T, Williams RJ, Califf RM, Ide NC. The ClinicalTrials.gov results database-update and key issues. N Engl J Med 2011;364:852-60.
18. Gillen JE, Tse T, Ide NC, McCray AT. Design, implementation and management of a web-based data entry system for ClinicalTrials.gov. Stud Health Technol Inform 2004;107(Pt 2):1466-70.
19. ClinicalTrials.gov. Glossary of common site terms. National Institutes of Health.
20. Viergever RF, Ghersi D. The quality of registration of clinical trials. PLoS One 2011;6:e14701.
21. Krzyzanowska MK, Pintilie M, Tannock IF. Factors associated with failure to publish large randomized trials presented at an oncology meeting. JAMA 2003;290:495-501.
22. Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med 2001;135:982-9.
23. LeLorier J, Gregoire G, Benhaddad A, Lapierre J, Derderian F. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 1997;337:536-42.
24. Ioannidis JP. Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials. JAMA 1998;279:281-6.
25. Bourgeois FT, Murthy S, Mandl KD. Outcome reporting among drug trials registered in ClinicalTrials.gov. Ann Intern Med 2010;153:158-66.
26. Ross JS, Tse T, Zarin DA, Xu H, Zhou L, Krumholz HM. Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis. BMJ 2011;344:d7292.
27. Ross JS, Mulvey GK, Hines EM, Nissen SE, Krumholz HM. Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis. PLoS Med 2009;6:e1000144.
28. Chan AW, Krleza-Jeric K, Schmid I, Altman DG. Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ 2004;171:735-40.
29. Toma M, McAlister FA, Bialy L, Adams D, Vandermeer B, Armstrong PW. Transition from meeting abstract to full-length journal article for randomized controlled trials. JAMA 2006;295:1281-7.
30. Von Elm E, Rollin A, Blumle A, Huwiler K, Witschi M, Egger M. Publication and non-publication of clinical trials: longitudinal study of applications submitted to a research ethics committee. Swiss Med Wkly 2008;138:197-203.
31. Turner EH, Knoepflmacher D, Shapley L. Publication bias in antipsychotic trials: an analysis of efficacy comparing the published literature to the US Food and Drug Administration database. PLoS Med 2012;9:e1001189.
32. Lee K, Bacchetti P, Sim I. Publication of clinical trials supporting successful new drug applications: a literature analysis. PLoS Med 2008;5:e191.
33. Hopewell S, Loudon K, Clarke MJ, Oxman AD, Dickersin K. Publication bias in clinical trials due to statistical significance or direction of trial results. Cochrane Database Syst Rev 2009:MR000006.
34. Song F, Parekh S, Hooper L, Loke YK, Ryder J, Sutton AJ, et al. Dissemination and publication of research findings: an updated review of related biases. Health Technol Assess 2010;14:iii, ix-xi, 1-193.
35. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet 1991;337:867-72.
36. Blumenthal D, Campbell EG, Anderson MS, Causino N, Louis KS. Withholding research results in academic life science. Evidence from a national survey of faculty. JAMA 1997;277:1224-8.
37. Campbell EG, Clarridge BR, Gokhale M, Birenbaum L, Hilgartner S, Holtzman NA, et al. Data withholding in academic genetics: evidence from a national survey. JAMA 2002;287:473-80.
38. Clinicaltrials.gov. About the results database. National Institutes of Health.
39. Mathieu S, Boutron I, Moher D, Altman DG, Ravaud P. Comparison of registered and published primary outcomes in randomized controlled trials. JAMA 2009;302:977-84.
40. Jones CW, Platts-Mills TF. Quality of registration for clinical trials published in emergency medicine journals. Ann Emerg Med 2012;60:458-64 e1.
41. Dekkers OM, Soonawala D, Vandenbroucke JP, Egger M. Reporting of noninferiority trials was incomplete in trial registries. J Clin Epidemiol 2011;64:1034-8.
42. Sekeres M, Gold JL, Chan AW, Lexchin J, Moher D, Van Laethem ML, et al. Poor reporting of scientific leadership information in clinical trial registers. PLoS One 2008;3:e1610.
43. McGee RG, Su M, Kelly PJ, Higgins GY, Craig JC, Webster AC. Trial registration and declaration of registration by authors of randomized controlled trials. Transplantation 2011;92:1094-100.
44. Califf RM, Zarin DA, Kramer JM, Sherman RE, Aberle LH, Tasneem A. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010. JAMA 2012;307:1838-47.
45. Prayle AP, Hurley MN, Smyth AR. Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study. BMJ 2012;344:d7373.
46. Cobo E, Selva-O'Callagham A, Ribera JM, Cardellach F, Dominguez R, Vilardell M. Statistical reviewers improve reporting in biomedical articles: a randomized trial. PLoS One 2007;2:e332.
47. Goodman SN, Berlin J, Fletcher SW, Fletcher RH. Manuscript quality before and after peer review and editing at Annals of Internal Medicine. Ann Intern Med 1994;121:11-21.
48. Nieminen P, Carpenter J, Rucker G, Schumacher M. The relationship between quality of research and citation frequency. BMC Med Res Methodol 2006;6:42.
49. Callaham M, Wears RL, Weber E. Journal prestige, publication bias, and other characteristics associated with citation of published studies in peer-reviewed journals. JAMA 2002;287:2847-50.
50. Strech D. Normative arguments and new solutions for the unbiased registration and publication of clinical trials. J Clin Epidemiol 2012;65:276-81.
51. Federal Policy for the Protection of Human Subjects. 45 CFR §46 (2009).
52. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. WMA General Assembly:1-5.
53. Levin LA, Palmer JG. Institutional review boards should require clinical trial registration. Arch Intern Med 2007;167:1576-80.